Epidermal growth factor receptor targeting in head and neck cancer: have we been just skimming the surface?
- PMID: 23460713
- DOI: 10.1200/JCO.2012.47.9220
Epidermal growth factor receptor targeting in head and neck cancer: have we been just skimming the surface?
Comment on
-
Cisplatin and radiotherapy with or without erlotinib in locally advanced squamous cell carcinoma of the head and neck: a randomized phase II trial.J Clin Oncol. 2013 Apr 10;31(11):1415-21. doi: 10.1200/JCO.2012.46.3299. Epub 2013 Mar 4. J Clin Oncol. 2013. PMID: 23460709 Clinical Trial.
-
Phase III randomized, placebo-controlled trial of docetaxel with or without gefitinib in recurrent or metastatic head and neck cancer: an eastern cooperative oncology group trial.J Clin Oncol. 2013 Apr 10;31(11):1405-14. doi: 10.1200/JCO.2012.45.4272. Epub 2013 Mar 4. J Clin Oncol. 2013. PMID: 23460714 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
